DE3270716D1 - Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity - Google Patents

Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity

Info

Publication number
DE3270716D1
DE3270716D1 DE8282300946T DE3270716T DE3270716D1 DE 3270716 D1 DE3270716 D1 DE 3270716D1 DE 8282300946 T DE8282300946 T DE 8282300946T DE 3270716 T DE3270716 T DE 3270716T DE 3270716 D1 DE3270716 D1 DE 3270716D1
Authority
DE
Germany
Prior art keywords
guanidino
histamine
substituted heterocyclic
antagonist activity
heterocyclic derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282300946T
Other languages
English (en)
Inventor
Tobias Oregon Yellin
David John Gilman
Philip Neil Edwards
Michael Stewart Large
Derrick Fleet Jones
Keith Oldham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Zeneca Inc
Original Assignee
Imperial Chemical Industries Ltd
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd, ICI Americas Inc filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of DE3270716D1 publication Critical patent/DE3270716D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8282300946T 1981-02-27 1982-02-24 Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity Expired DE3270716D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8106376 1981-02-27
GB8113664 1981-05-05

Publications (1)

Publication Number Publication Date
DE3270716D1 true DE3270716D1 (en) 1986-05-28

Family

ID=26278598

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282300946T Expired DE3270716D1 (en) 1981-02-27 1982-02-24 Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity

Country Status (4)

Country Link
US (2) US4496571A (de)
EP (1) EP0059597B1 (de)
CA (1) CA1209999A (de)
DE (1) DE3270716D1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR71929B (de) * 1979-11-13 1983-08-19 Ici Ltd
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
JPS59167570A (ja) * 1983-03-04 1984-09-21 バイエル・アクチエンゲゼルシヤフト グアニジン誘導体
DE3334455A1 (de) * 1983-03-04 1984-09-06 Bayer Ag, 5090 Leverkusen Guanidin - derivate
US4624958A (en) * 1983-04-14 1986-11-25 Pfizer Inc. Antiprotozoal 1,4-di(p-amidinophenyl)imidazoles
FR2626004B1 (fr) * 1988-01-20 1991-08-02 Rhone Poulenc Sante Procede de preparation du (pyridyl-3)-3 1h, 3h-pyrrolo (1,2-c) thiazolecarbonitrile-7
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5616722A (en) * 1995-12-05 1997-04-01 Mcintyre Group, Ltd. Antimicrobial solution of formaldehyde substituted hydantoin and process for preparation
DZ3415A1 (fr) * 2000-08-31 2002-03-07 Chiron Corp Guanidinobenzamides comme mc4-r agonistes.
ES2278016T3 (es) * 2001-04-09 2007-08-01 Novartis Vaccines And Diagnostics, Inc. Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
JP2005524649A (ja) * 2002-02-25 2005-08-18 カイロン コーポレーション Ｍｃ４−ｒアゴニストの鼻腔内投与
WO2003099818A1 (en) * 2002-05-23 2003-12-04 Chiron Corporation Substituted quinazolinone compounds
EP1651229A1 (de) * 2003-05-23 2006-05-03 Chiron Corporation Guanidino-substituierte chinazolinon-verbindungen als mc4-r agonisten
US7368453B2 (en) * 2003-11-19 2008-05-06 Chiron Corporation Quinazolinone compounds with reduced bioaccumulation
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186965A (en) * 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
DE2961923D1 (en) * 1978-01-18 1982-03-11 Ici Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
DE2963363D1 (en) * 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
ATE852T1 (de) * 1978-05-24 1982-04-15 Imperial Chemical Industries Plc Anti-sekretion oxadiazol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
EP0010893B1 (de) * 1978-10-16 1984-02-08 Imperial Chemical Industries Plc Verzweigtkettige heterozyklische Guanidinderivate mit antisekretorischer Wirkung, Verfahren zu ihrer Herstellung, Zwischenprodukte und die genannten Derivate enthaltende pharmazeutische Zusammensetzungen
EP0014057B1 (de) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them
GR71929B (de) * 1979-11-13 1983-08-19 Ici Ltd
EP0045155B1 (de) * 1980-07-30 1985-01-02 Imperial Chemical Industries Plc Guanidinderivate
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists

Also Published As

Publication number Publication date
EP0059597B1 (de) 1986-04-23
US4496571A (en) 1985-01-29
US4657908A (en) 1987-04-14
EP0059597A2 (de) 1982-09-08
EP0059597A3 (en) 1982-11-17
CA1209999A (en) 1986-08-19

Similar Documents

Publication Publication Date Title
ZW13185A1 (en) Heterocyclic derivatives
GB2131428B (en) Amine derivatives having histamine h2-blocking activity
EP0182054A3 (en) Heterocyclic compounds
DE3270716D1 (en) Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
EG17800A (en) Heterocyclic compounds
IL67185A0 (en) Heterocyclic compounds
GB8405368D0 (en) Heterocyclic compounds
DE3274856D1 (en) Heterocyclic derivatives
PT75828A (en) Heterocyclic compounds
GB8408615D0 (en) Heterocyclic compounds
AU1816883A (en) Thiazole derivatives with histamine h-2 antagonist activity
ZA849273B (en) Pyridone derivatives with histamine h2-receptor antagonist activity
EP0181145A3 (en) Heterocyclic compounds
GB8410989D0 (en) Heterocyclic compounds
PH18754A (en) Benzo-fused heterocyclic derivatives
DE3275291D1 (en) Heterocyclic derivatives
ZA821307B (en) Heterocyclic derivatives
GB8401888D0 (en) Heterocyclic compounds
GB8303097D0 (en) Heterocyclic derivatives
ZA825315B (en) Heterocyclic derivatives
ZA824141B (en) Heterocyclic derivatives
ZM1882A1 (en) Heterocyclic derivatives
GB8424251D0 (en) Heterocyclic derivatives
GB8424250D0 (en) Heterocyclic derivatives
ZA855891B (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee